M. Vazakidou

发表

Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth

V. Gorgoulis, I. Kalomenidis, C. Moschos, 2018, Oncoimmunology.

Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer

I. Asangani, M. A. Siddiqui, P. Ceppi, 2020, British journal of cancer.

Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer

I. Asangani, M. A. Siddiqui, P. Ceppi, 2020, bioRxiv.

Thymidylate synthase maintains the de-differentiated state of aggressive breast cancers

I. Asangani, S. A. K. Rasheed, J. Schellens, 2018, bioRxiv.

Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers

I. Asangani, S. A. K. Rasheed, P. Ceppi, 2019, Cell Death & Differentiation.

Mammalian target of rapamycin (mTOR) inhibition does not prevent lung adenocarcinoma‐induced malignant pleural effusion

I. Kalomenidis, M. Vazakidou, C. Moschos, 2014, Respirology.

Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implications

V. Gorgoulis, I. Kalomenidis, C. Moschos, 2018, Oncotarget.

Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo

I. Kalomenidis, C. Moschos, I. Psallidas, 2015, Respirology.

Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells.

P. Oefner, S. A. K. Rasheed, A. Ekici, 2018, Cancer research.

Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial‐to‐mesenchymal transition of cancer cells

P. Ceppi, I. Rapa, T. Brabletz, 2017, The Journal of pathology.

Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion

I. Kalomenidis, C. Moschos, K. Psarra, 2016, Oncotarget.

Role of angiopoietins in mesothelioma progression.

I. Kalomenidis, M. Spella, G. Stathopoulos, 2019, Cytokine.